Efficacy of Crizotinib, Ceritinib, and Alectinib in ALK-Positive Non-Small Cell Lung Cancer Treatment: A Meta-Analysis of Clinical Trials

This study aimed to evaluate the efficacy of anaplastic lymphoma kinase (ALK)-inhibitors in the treatment of ALK-positive non-small cell lung cancer (NSCLC) by using a meta-analysis of clinical trials. We searched PubMed, EMBASE, Cochrane Library, and Clinicaltrials.gov by using keywords related to...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoang, Tung, Myung, Seung-Kwon, Pham, Thu Thi, Park, Boyoung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139871/
https://www.ncbi.nlm.nih.gov/pubmed/32106398
http://dx.doi.org/10.3390/cancers12030526

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139871/
https://www.ncbi.nlm.nih.gov/pubmed/32106398
http://dx.doi.org/10.3390/cancers12030526

Ejemplares similares